MORGAN STANLEY PLC/CALL/MERCK & CO./120/0.1/20.09.24 Share Price

Warrant

DE000MB0CZT5

Real-time Bid/Ask 07:49:08 01/07/2024 BST
0.8 EUR / 0.84 EUR -27.43% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./120/0.1/20.09.24
Current month+26.97%
1 month+1.80%
Date Price Change
28/06/24 1.13 -1.74%
27/06/24 1.15 -23.84%
26/06/24 1.51 +0.67%
25/06/24 1.5 +3.45%
24/06/24 1.45 +16.94%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 07:30 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB0CZT
ISINDE000MB0CZT5
Date issued 09/11/2022
Strike 120 $
Maturity 20/09/2024 (82 Days)
Parity 10 : 1
Emission price 0.94
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.6
Lowest since issue 0.169
Spread 0.01
Spread %1.03%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8 USD
Average target price
142.7 USD
Spread / Average Target
+15.25%
Consensus